{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 0,
  "authors": [],
  "bibtex": "https://research.draconitic.com/paper/10txzavbs0c02.bib",
  "cited_by": 0,
  "doi": null,
  "fulltext_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13702908/?tool=EBI",
  "id": "10txzavbs0c02",
  "issns": [
    "1467-3037",
    "1467-3045"
  ],
  "landing_url": "https://europepmc.org/article/PMC/PMC13702908",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13702908/pdf/?tool=EBI",
  "pmcid": "PMC13702908",
  "pmid": null,
  "published": "2026-09-24",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/10txzavbs0c02.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:21:51Z",
      "native_id": "PMC:PMC13702908",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13702908"
    }
  ],
  "subjects": [],
  "title": "Emapalumab in IFN-γ-Driven Hyperinflammatory Disorders: Mechanisms, Clinical Evidence, and Emerging Therapeutic Applications",
  "title_text": "Emapalumab in IFN-γ-Driven Hyperinflammatory Disorders: Mechanisms, Clinical Evidence, and Emerging Therapeutic Applications",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:21:51Z",
  "url": "https://research.draconitic.com/paper/10txzavbs0c02",
  "venue": "Current issues in molecular biology",
  "versions": []
}